(TDG) Transdigm - Overview
Stock: Actuators, Valves, Motors, Seals, Restraints
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.90% |
| Yield on Cost 5y | 18.13% |
| Yield CAGR 5y | 69.44% |
| Payout Consistency | 44.3% |
| Payout Ratio | 3.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 33.7% |
| Relative Tail Risk | 0.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.22 |
| Alpha | -5.12 |
| Character TTM | |
|---|---|
| Beta | 0.687 |
| Beta Downside | 0.743 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.98% |
| CAGR/Max DD | 1.54 |
Description: TDG Transdigm January 27, 2026
TransDigm Group Inc. (NYSE: TDG) designs, manufactures, and supplies a broad portfolio of aircraft components across three operating segments: Power & Control, Airframe, and Non-Aviation. The Power & Control segment focuses on actuators, ignition systems, pumps, motors, batteries, and related electronic hardware; the Airframe segment delivers latching devices, cockpit systems, interior furnishings, lighting, and testing equipment; the Non-Aviation segment provides safety restraints, hydraulic actuators, refueling and turbine controls for off-road, child-restraint, and space-system markets. The company serves a mix of OEMs, airlines, military agencies, and third-party maintenance providers worldwide.
In the most recent quarter (Q2 2024), TDG posted revenue of $1.12 billion, a 9 % year-over-year increase, and an operating margin of 31 %, reflecting strong pricing power and cost discipline. The firm’s backlog stood at roughly $2.5 billion, indicating a multi-year pipeline of orders. Key macro drivers include the projected 2025 global commercial aircraft delivery volume of ~2,400 units-a 5 % rise versus 2024-and a 6 % increase in the U.S. defense budget for FY 2025, both of which underpin demand for TDG’s aerospace and defense components.
If you want a deeper, data-rich assessment of TDG’s valuation dynamics, a quick look at ValueRay’s analyst toolkit may be worthwhile.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 2.07b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.58 > 1.0 |
| NWC/Revenue: 54.70% < 20% (prev 46.47%; Δ 8.23% < -1%) |
| CFO/TA 0.09 > 3% & CFO 2.04b > Net Income 2.07b |
| Net Debt (27.22b) to EBITDA (4.57b): 5.96 < 3 |
| Current Ratio: 3.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (58.1m) vs 12m ago 0.17% < -2% |
| Gross Margin: 60.15% > 18% (prev 0.59%; Δ 5956 % > 0.5%) |
| Asset Turnover: 36.42% > 50% (prev 31.03%; Δ 5.38% > 0%) |
| Interest Coverage Ratio: 2.67 > 6 (EBITDA TTM 4.57b / Interest Expense TTM 1.57b) |
Altman Z'' 0.70
| A: 0.21 (Total Current Assets 7.01b - Total Current Liabilities 2.18b) / Total Assets 22.91b |
| B: -0.46 (Retained Earnings -10.61b / Total Assets 22.91b) |
| C: 0.17 (EBIT TTM 4.20b / Avg Total Assets 24.25b) |
| D: -0.33 (Book Value of Equity -10.62b / Total Liabilities 32.59b) |
| Altman-Z'' Score: 0.70 = B |
Beneish M -2.84
| DSRI: 1.05 (Receivables 1.62b/1.38b, Revenue 8.83b/7.94b) |
| GMI: 0.98 (GM 60.15% / 58.85%) |
| AQI: 1.14 (AQ_t 0.62 / AQ_t-1 0.55) |
| SGI: 1.11 (Revenue 8.83b / 7.94b) |
| TATA: 0.00 (NI 2.07b - CFO 2.04b) / TA 22.91b) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
What is the price of TDG shares?
Over the past week, the price has changed by -9.95%, over one month by -7.14%, over three months by +1.10% and over the past year by +6.27%.
Is TDG a buy, sell or hold?
- StrongBuy: 14
- Buy: 4
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TDG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1622.1 | 26.2% |
| Analysts Target Price | 1622.1 | 26.2% |
| ValueRay Target Price | 1709.7 | 33% |
TDG Fundamental Data Overview February 03, 2026
P/E Forward = 35.5872
P/S = 9.1091
P/EG = 3.4522
Revenue TTM = 8.83b USD
EBIT TTM = 4.20b USD
EBITDA TTM = 4.57b USD
Long Term Debt = 29.17b USD (from longTermDebt, last quarter)
Short Term Debt = 863.0m USD (from shortTermDebt, last quarter)
Debt = 30.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 27.22b USD (from netDebt column, last quarter)
Enterprise Value = 107.66b USD (80.44b + Debt 30.03b - CCE 2.81b)
Interest Coverage Ratio = 2.67 (Ebit TTM 4.20b / Interest Expense TTM 1.57b)
EV/FCF = 59.29x (Enterprise Value 107.66b / FCF TTM 1.82b)
FCF Yield = 1.69% (FCF TTM 1.82b / Enterprise Value 107.66b)
FCF Margin = 20.57% (FCF TTM 1.82b / Revenue TTM 8.83b)
Net Margin = 23.49% (Net Income TTM 2.07b / Revenue TTM 8.83b)
Gross Margin = 60.15% ((Revenue TTM 8.83b - Cost of Revenue TTM 3.52b) / Revenue TTM)
Gross Margin QoQ = 60.32% (prev 59.54%)
Tobins Q-Ratio = 4.70 (Enterprise Value 107.66b / Total Assets 22.91b)
Interest Expense / Debt = 1.40% (Interest Expense 420.0m / Debt 30.03b)
Taxrate = 19.12% (144.0m / 753.0m)
NOPAT = 3.40b (EBIT 4.20b * (1 - 19.12%))
Current Ratio = 3.21 (Total Current Assets 7.01b / Total Current Liabilities 2.18b)
Debt / Equity = -3.10 (negative equity) (Debt 30.03b / totalStockholderEquity, last quarter -9.69b)
Debt / EBITDA = 5.96 (Net Debt 27.22b / EBITDA 4.57b)
Debt / FCF = 14.99 (Net Debt 27.22b / FCF TTM 1.82b)
Total Stockholder Equity = -6.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.55% (Net Income 2.07b / Total Assets 22.91b)
RoE = -31.17% (negative equity) (Net Income TTM 2.07b / Total Stockholder Equity -6.65b)
RoCE = 18.67% (EBIT 4.20b / Capital Employed (Equity -6.65b + L.T.Debt 29.17b))
RoIC = 17.32% (NOPAT 3.40b / Invested Capital 19.63b)
WACC = 6.46% (E(80.44b)/V(110.47b) * Re(8.45%) + D(30.03b)/V(110.47b) * Rd(1.40%) * (1-Tc(0.19)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.35%
[DCF Debug] Terminal Value 86.45% ; FCFF base≈1.84b ; Y1≈2.27b ; Y5≈3.87b
Fair Price DCF = 1196 (EV 94.58b - Net Debt 27.22b = Equity 67.36b / Shares 56.3m; r=6.46% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -4.40 | EPS CAGR: -38.31% | SUE: -4.0 | # QB: 0
Revenue Correlation: 97.28 | Revenue CAGR: 20.96% | SUE: 0.70 | # QB: 0
EPS next Quarter (2026-03-31): EPS=9.20 | Chg30d=-0.015 | Revisions Net=-2 | Analysts=17
EPS current Year (2026-09-30): EPS=38.62 | Chg30d=+0.233 | Revisions Net=+4 | Growth EPS=+3.5% | Growth Revenue=+12.4%
EPS next Year (2027-09-30): EPS=46.08 | Chg30d=+0.375 | Revisions Net=+4 | Growth EPS=+19.3% | Growth Revenue=+7.9%